Current Pharmacogenomics and Personalized Medicine
Title: Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology]
Volume: 8 Issue: 2
Author(s): James M. Flanagan
Affiliation:
Keywords: Epigenetic epidemiology, epigenetics, genomics, genome-environment interaction, methylome, personalized medicine, plasticity
Export Options
About this article
Cite this article as:
M. Flanagan James, Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology], Current Pharmacogenomics and Personalized Medicine 2010; 8 (2) . https://dx.doi.org/10.2174/187569210791383965
DOI https://dx.doi.org/10.2174/187569210791383965 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Cancer Stem Cells: The ‘Achilles Heel’ of Chemo-Resistant Tumors
Recent Patents on Anti-Cancer Drug Discovery GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews Synthesis and Biological Evaluation of 1, 3-Dihydroxyxanthone Mannich Base Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery Radiolabelling of Ascorbic Acid: A New Clue to Clarify its Action as an Anticancer Agent?
Current Radiopharmaceuticals Paraneoplastic Pemphigus: Autoimmune-Cancer Nexus in the Skin
Anti-Cancer Agents in Medicinal Chemistry Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Current Scenario of 1,4-Diazepines as Potent Biomolecules-A Mini Review
Mini-Reviews in Medicinal Chemistry Investigation of in Vitro Release Dynamics of Cisplatin from Genipin Crosslinked Gelatin Nanocarriers
Drug Delivery Letters Lipid-based Nano-phytomedicines for Disease Treatment and Theranostic Applications
Current Nanomedicine Killer Beacons for Combined Cancer Imaging and Therapy
Current Medicinal Chemistry PI3K Pathway Inhibitors: Better Not Left Alone
Current Pharmaceutical Design Duloxetine in the Treatment of Depression: An Overview
Central Nervous System Agents in Medicinal Chemistry Soluble Guanylate Cyclase: A New Therapeutic Target for Fibrotic Diseases
Current Medicinal Chemistry Photoactivatable Platinum Complexes
Anti-Cancer Agents in Medicinal Chemistry The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry Targeting 5-Lipoxygenase for Prevention and Treatment of Cancer
Current Enzyme Inhibition Proline-Directed Protein Kinase FA as a Potential Target for Diagnosis and Therapy of Human Cancers
Current Cancer Drug Targets Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews